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Global Availability of Cancer Registry
Data
TO THE EDITOR:
The availability of cancer registries has significantly enhanced cancer research, especially
that related to cancer epidemiology, survival,
interventions, and outcomes.1 However, by using
publicly available sources, we aimed to map the
availability and extent of cancer registry data in
each country. We also aimed to test the association of registry data with metadata such as country income and national cancer-related policies.
Data from 190 countries were collected from the
WHO country cancer profiles.2 We sought data
on the presence of an operational national cancer control policy, strategy, or action plan and
the presence of a cancer registry. If those data
were present, we looked for additional details
on the cancer registry, including whether the
registry was population based or hospital based
and, if it was population based, whether there
was national or subnational coverage. Complete
data from Réunion (French), South Sudan, Guadeloupe (French), Martinique (French), Guyana,
Puerto Rico, West Bank, Gaza Strip, and New
Caledonia (French) were not available and thus
were not included in our analyses. The availability of cancer registry data worldwide was
depicted as a choropleth map using eSpatial
mapping software.3
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Metadata on income status and health care
expenditures were collected from the World
Bank.4 Countries were classified by income
into four categories: high income, upper-middle
income, lower-middle income, and low income.
We used the χ2 test to study the associations
between country income status, health care
expenditures, the presence of national cancer
control policies, and the availability of cancer
registry data.
We included 56 high-income countries (HICs),
55 upper-middle-income countries (UMICs),
50 lower-middle-income countries (LMICs),
and 29 low-income countries (LICs). In 2015,
the global population was 7,316,582,000, of
which 1,190,048,000 (16%) lived in HICs,

1

2,622,663,000 (36%) in UMICs, 2,910,442,000
(40%) in LMICs, and 593,429,000 (8%) in LICs.
Although each income group spent a similar percentage of their gross domestic profit on health
care (HICs, 7.82%; UMICs, 6.98%; LMICs,
5.86%; and LICs, 6.21%), the mean per capita health expenditure varied widely with HICs
spending $3,224, UMICs spending $515, LMICs
spending $141, and LICs spending $39 per person (all in US dollars; Table 1).
Only 60% of all countries had national cancer
control policies, strategies, or action plans. Most
of these (65%) were HICs or UMICs. Of the 190
countries investigated, 50 (26%) did not have
any kind of cancer registry. Of the 140 countries with a registry, 99 (71%) had a population-based registry, and 81 (58%) had national
coverage (Fig 1).
Income status was associated with the presence of a registry (P = .003) and with the presence of a national cancer control policy (P =
.005). Only 22% of LICs had a national cancer
registry compared with 75% of HICs. Similarly,
only 31% of LICs had a national cancer control
plan compared with 79% of HICs (Table 1).
The presence of a national cancer control policy was also associated with the presence of a
cancer registry (P < .001). A cancer registry
was present in 89% of countries with a national
cancer control policy in place compared with
60% of countries without a national policy. This
difference held even for LICs in which 72%
of those with a national cancer strategy had a
cancer registry versus 53% of those without a
national strategy.
We observed a large variation in the presence
of cancer registry data among countries. The
availability of such data was related to a county’s
income status and the mean per capita health
expenditures. LICs and LMICs were found to
have the least cancer registry data. This lack
of data has a significant impact on the ability of
LMICs to provide cancer care. Without epidemiologic data from population-based registries,
jgo.org JGO – Journal of Global Oncology

© 2018 by American Society of Clinical Oncology

Licensed under the Creative Commons Attribution 4.0 License

Downloaded from ascopubs.org by The Aga Khan University on March 7, 2019 from 221.132.113.069
Copyright © 2019 American Society of Clinical Oncology. All rights reserved.

Table 1. Country Metadata With the Presence and Scope of Cancer Registries by Income Level
Income Level
High
Metadata

No.

No. of countries
2015 population (in
thousands)

%

Upper Middle

Lower Middle

No.

No.

%

Total

No.

%

No.

56

55

50

29

190

1,190,048

2,622,663

2,910,442

593,429

7,316,582

2014 mean GDP health
expenditure

7.82

2014 mean per capita
health expenditure
(US dollars)

%

Low

3,224

6.98
515

5.86
141

%

P

6.21
39

Presence of national
cancer control policy,
strategy, or plan

44

79

31

66

31

65

7

31

113

60

.005

Presence of a cancer
registry

53

95

38

79

35

73

14

61

140

74

.003

Population-based cancer
registry

49

89

27

71

16

47

7

50

99

52

< .001

National coverage for
cancer registry

39

75

24

53

13

34

5

22

81

43

< .001

Abbreviation: GDP, gross domestic profit.

Fig 1. Global variation
in the availability of cancer
registry data.

assessment of the burden of cancer in a country is limited. This makes it difficult for governments to allocate appropriate resources for
cancer care or to measure the performance of
specific interventions.

We found an association between the availability
of registry data and the presence of a national
cancer control policy, even in LMICs. Working
with governments to establish national cancer
strategies and action plans may be a successful

= No data
= No registry
= Subnational, hospital based
= Subnational, population based
= National
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means of encouraging them to create cancer registries. There are several examples of resourcepoor countries with viable cancer registries.5 We
must learn from these examples to lobby clinicians, scientists, administrators, and policy makers to enhance the formation and maintenance
of cancer registries globally. Improving global

cancer registry data is a vital first step in improving cancer care and cancer research around the
world.
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